Today's stock market news, April 4, 2014: The Dow Jones Industrial Average fell 0.45 points on Thursday to finish at 16,572.55. The Nasdaq dropped 38.72 points finish at 4,237.74 yesterday, while the S&P 500 was down 2.13 points to end the day at 1,888.77.
biggest stock market news today
- Today's Stock Market News: GrubHub Debuts, Letterman Announces Finish
- Top Stock Market News Today: Tesla Puts Up a Fight
- The Biggest Stock Market News Today, March 27, 2014
- This Cutting-Edge Drug Has Endocyte (Nasdaq: ECYT) Stock Soaring
- Biggest Stock Market News Today, Dec. 2
Top stock market news today, April 3, 2014: The Dow Jones Industrial Average was up 40.39 points yesterday to finish at 16,573.00. The Nasdaq increased 8.42 points, finishing at 4,276.46, while the S&P 500 climbed 5.38 points to finish at 1,890.90. The S&P 500 touched another record yesterday on positive economic data. February factory orders increased, while private-sector hiring in March increased to its fastest rate in three months.
Stock futures were up this morning, following news that China will likely increase stimulus efforts in the coming months in order to support its 7.5% targeted growth rate.
Biggest Stock market news today, March 27, 2014: The Dow Jones Industrial Average dropped 98.89 points to finish at 16,268.99 on Wednesday. The Nasdaq fell 60.69 points close at 4,173.58, while the S&P 500 slipped 13.06 points to settle at 1,852.56.
On Thursday, investors will be looking to GDP revisions and for any good news in the housing market. A gain in pending home sales would be surprising, and would increase the summer outlook for home sales.
Endocyte Inc. (Nasdaq: ECYT) stock skyrocketed over 130% today (Friday) after the Indiana-based biopharma won market approval for its first drug, a cancer therapeutic called "vintafolide." The drug was developed in collaboration with Merck & Co. (NYSE: MRK).
Today, Merck announced the European Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion of vintafolide, along with its companion imaging agent, etarfolatide. The drugs were part of a group CHMP voted to approve during a March 17-20 meeting.
Stock Market News Today, Dec. 2: U.S. stocks are trading lower today despite positive momentum in online sales and positive manufacturing data.